Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.3B | 4.0B | 4.5B | 3.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 499.9M | 505.3M | 550.0M | 693.7M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 52.1M | 52.8M | 53.4M | 52.6M |
Other income expense | 1.2B | 1.4B | 1.3B | 1.5B |
Pretax income | 157.8M | 723.5M | 1.2B | 366.1M |
Tax provision | 28.4M | 162.1M | 259.4M | 76.2M |
Net income | 129.3M | 561.4M | 946.9M | 289.9M |
Basic EPS | 12.1 | 38.8 | 66.4 | 18.7 |
Diluted EPS | 12.1 | 38.7 | 66.3 | 18.6 |
Basic average shares | 12.8M | 12.9M | 13.0M | 13.1M |
Diluted average shares | 12.8M | 12.9M | 13.0M | 13.1M |
EBITDA | — | — | — | — |
Net income from continuing op. | 129.3M | 561.4M | 946.9M | 289.9M |
Minority interests | -7.6M | -12.3M | -42.0M | -22.1M |
Preferred stock dividends | -33.3M | 30.4M | 42.6M | 6.1M |